1.
Drug Evaluation Research
;
(6): 424-427, 2017.
Article
in Chinese
| WPRIM
| ID: wpr-514044
ABSTRACT
Hepatitis B is a serious hazard to human health.This paper describes the current clinical use of several nucleoside antiviral drugs combination,and introduces the candidate drugs which are able to effectively inhibit the hepatitis B virus replication in vivo and in vitro in two years,which provides reference for the research and development of new anti-HBV drugs.